Showing results (1281-1290 of 1,328) with videos related to

Sort By:
Pageof 133
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Bipolar Disorders|August 30, 2019
Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task ForceIves C Passos, Pedro L Ballester, Rodrigo C Barros, et al.
Journal of Affective Disorders|September 3, 2020
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysisRoger S McIntyre, Isabelle P Carvalho, Leanna M W Lui, et al.
Frontiers in Psychiatry|February 13, 2023
Differentiating people with schizophrenia from healthy controls in a developing Country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic toolBach Xuan Tran, Tham Thi Nguyen, Laurent Boyer, et al.
Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.
Journal of Affective Disorders|August 21, 2024
Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Sipan Haikazian, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.
Pageof 133